These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33790946)

  • 21. Development of a Nomogram With Alternative Splicing Signatures for Predicting the Prognosis of Glioblastoma: A Study Based on Large-Scale Sequencing Data.
    Wang Z; Gao L; Guo X; Feng C; Lian W; Deng K; Xing B
    Front Oncol; 2020; 10():1257. PubMed ID: 32793502
    [No Abstract]   [Full Text] [Related]  

  • 22. A Five-lncRNAs Signature-Derived Risk Score Based on TCGA and CGGA for Glioblastoma: Potential Prospects for Treatment Evaluation and Prognostic Prediction.
    Niu X; Sun J; Meng L; Fang T; Zhang T; Jiang J; Li H
    Front Oncol; 2020; 10():590352. PubMed ID: 33392085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An Integrated Model Based on a Six-Gene Signature Predicts Overall Survival in Patients With Hepatocellular Carcinoma.
    Li W; Lu J; Ma Z; Zhao J; Liu J
    Front Genet; 2019; 10():1323. PubMed ID: 32010188
    [No Abstract]   [Full Text] [Related]  

  • 24. Integrated analysis of single-cell RNA-seq dataset and bulk RNA-seq dataset constructs a prognostic model for predicting survival in human glioblastoma.
    Lai W; Li D; Kuang J; Deng L; Lu Q
    Brain Behav; 2022 May; 12(5):e2575. PubMed ID: 35429411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and validation of a nomogram with an autophagy-related gene signature for predicting survival in patients with glioblastoma.
    Wang Z; Gao L; Guo X; Feng C; Lian W; Deng K; Xing B
    Aging (Albany NY); 2019 Dec; 11(24):12246-12269. PubMed ID: 31844032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA signatures predict prognosis of patients with glioblastoma multiforme through the Cancer Genome Atlas.
    Yuan Y; Zhang H; Liu X; Lu Z; Li G; Lu M; Tao X
    Oncotarget; 2017 Aug; 8(35):58386-58393. PubMed ID: 28938564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Construction and validation of a glioblastoma prognostic model based on immune-related genes.
    Huang K; Rao C; Li Q; Lu J; Zhu Z; Wang C; Tu M; Shen C; Zheng S; Chen X; Lv F
    Front Neurol; 2022; 13():902402. PubMed ID: 35968275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a Five-Gene Signature and Establishment of a Prognostic Nomogram to Predict Progression-Free Interval of Papillary Thyroid Carcinoma.
    Wu M; Yuan H; Li X; Liao Q; Liu Z
    Front Endocrinol (Lausanne); 2019; 10():790. PubMed ID: 31803141
    [No Abstract]   [Full Text] [Related]  

  • 29. Prognostic risk model construction and molecular marker identification in glioblastoma multiforme based on mRNA/microRNA/long non-coding RNA analysis using random survival forest method.
    Wang H; Liu D; Yang J
    Neoplasma; 2019 May; 66(3):459-469. PubMed ID: 30784292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Risk Classification System With Five-Gene for Survival Prediction of Glioblastoma Patients.
    Wang Y; Liu X; Guan G; Zhao W; Zhuang M
    Front Neurol; 2019; 10():745. PubMed ID: 31379707
    [No Abstract]   [Full Text] [Related]  

  • 31. IDH mutation and MGMT promoter methylation are associated with the pseudoprogression and improved prognosis of glioblastoma multiforme patients who have undergone concurrent and adjuvant temozolomide-based chemoradiotherapy.
    Li H; Li J; Cheng G; Zhang J; Li X
    Clin Neurol Neurosurg; 2016 Dec; 151():31-36. PubMed ID: 27764705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Novel 16-Genes Signature Scoring System as Prognostic Model to Evaluate Survival Risk in Patients with Glioblastoma.
    Yu Z; Du M; Lu L
    Biomedicines; 2022 Jan; 10(2):. PubMed ID: 35203526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of a novel glycolysis-related gene expression signature for gastrointestinal cancer in the Asian population.
    Xia R; Tang H; Shen J; Xu S; Liang Y; Zhang Y; Gong X; Min Y; Zhang D; Tao C; Wang S; Zhang Y; Yang J; Wang C
    Cancer Cell Int; 2021 Mar; 21(1):154. PubMed ID: 33663535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An Immune-Related Six-lncRNA Signature to Improve Prognosis Prediction of Glioblastoma Multiforme.
    Zhou M; Zhang Z; Zhao H; Bao S; Cheng L; Sun J
    Mol Neurobiol; 2018 May; 55(5):3684-3697. PubMed ID: 28527107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular Predictors of Long-Term Survival in Glioblastoma Multiforme Patients.
    Lu J; Cowperthwaite MC; Burnett MG; Shpak M
    PLoS One; 2016; 11(4):e0154313. PubMed ID: 27124395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of alternative splicing signatures in the prognosis of glioblastoma.
    Xie ZC; Wu HY; Dang YW; Chen G
    Cancer Med; 2019 Dec; 8(18):7623-7636. PubMed ID: 31674730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A RNA sequencing-based six-gene signature for survival prediction in patients with glioblastoma.
    Zuo S; Zhang X; Wang L
    Sci Rep; 2019 Feb; 9(1):2615. PubMed ID: 30796273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic Prediction Model for Glioblastoma: A Metabolic Gene Signature and Independent External Validation.
    Lei C; Chen W; Wang Y; Zhao B; Liu P; Kong Z; Liu D; Dai C; Wang Y; Wang Y; Ma W
    J Cancer; 2021; 12(13):3796-3808. PubMed ID: 34093788
    [No Abstract]   [Full Text] [Related]  

  • 39. An Immune-Related Gene Pairs Signature for Predicting Survival in Glioblastoma.
    Wang S; Xu X
    Front Oncol; 2021; 11():564960. PubMed ID: 33859933
    [No Abstract]   [Full Text] [Related]  

  • 40. A radiomics nomogram based on multiparametric MRI might stratify glioblastoma patients according to survival.
    Zhang X; Lu H; Tian Q; Feng N; Yin L; Xu X; Du P; Liu Y
    Eur Radiol; 2019 Oct; 29(10):5528-5538. PubMed ID: 30847586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.